Literature DB >> 17932945

p107 acts as a tumor suppressor in pRb-deficient epidermis.

M Fernanda Lara1, Mirentxu Santos, Sergio Ruiz, Carmen Segrelles, Marta Moral, Ana Belén Martínez-Cruz, Pilar Hernández, Jesús Martínez-Palacio, Corina Lorz, Ramón García-Escudero, Jesús M Paramio.   

Abstract

The specific deletion of Rb gene in epidermis leads to altered proliferation and differentiation, but not to the development of spontaneous tumors. Our previous data have demonstrated the existence of a functional compensation of Rb loss by Rbl1 (p107) in as the phenotypic differences with respect to controls are intensified. However, the possible evolution of this aggravated phenotype, in particular in relationship with tumorigenesis, has not been evaluated due to the premature death of the double deficient mice. We have now investigated whether p107 can also act as a tumor suppressor in pRb-deficient epidermis using different experimental approaches. We found spontaneous tumor development in doubly-deficient skin grafts. Moreover, Rb-deficient keratinocytes are susceptible to Ha-ras-induced transformation, and this susceptibility is enhanced by p107 loss. Further functional analyses, including microarray gene expression profiling, indicated that the loss of p107, in the absence of pRb, produces the reduction of p53-dependent pro-apoptotic signals. Overall, our data demonstrate that p107 behaves as a tumor suppressor in epidermis in the absence of pRb and suggest novel tumor-suppressive roles for p107 in the context of functional p53 and activated Ras. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17932945     DOI: 10.1002/mc.20367

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  18 in total

1.  Distinct roles for p107 and p130 in Rb-independent cellular senescence.

Authors:  Brian D Lehmann; Adam M Brooks; Matthew S Paine; William H Chappell; James A McCubrey; David M Terrian
Journal:  Cell Cycle       Date:  2008-03-07       Impact factor: 4.534

2.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

3.  p107 in the public eye: an Rb understudy and more.

Authors:  Stacey E Wirt; Julien Sage
Journal:  Cell Div       Date:  2010-04-02       Impact factor: 5.130

4.  Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Authors:  Deborah L Burkhart; Stacey E Wirt; Anne-Flore Zmoos; Michael S Kareta; Julien Sage
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

5.  A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling.

Authors:  Corina Lorz; Ramón García-Escudero; Carmen Segrelles; Marina I Garín; José M Ariza; Mirentxu Santos; Sergio Ruiz; María F Lara; Ana B Martínez-Cruz; Clotilde Costa; Agueda Buitrago-Pérez; Cristina Saiz-Ladera; Marta Dueñas; Jesús M Paramio
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

6.  GFP reporter mice for the retinoblastoma-related cell cycle regulator p107.

Authors:  Deborah L Burkhart; Patrick Viatour; Victoria M Ho; Julien Sage
Journal:  Cell Cycle       Date:  2008-08-12       Impact factor: 4.534

7.  The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras.

Authors:  V M Ho; B E Schaffer; A N Karnezis; K S Park; J Sage
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

8.  p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.

Authors:  Cristina Saiz-Ladera; María Fernanda Lara; Marina Garín; Sergio Ruiz; Mirentxu Santos; Corina Lorz; Ramón García-Escudero; Mónica Martínez-Fernández; Ana Bravo; Oscar Fernández-Capetillo; Carmen Segrelles; Jesús M Paramio
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

9.  A novel tumor suppressor network in squamous malignancies.

Authors:  Clotilde Costa; Mirentxu Santos; Carmen Segrelles; Marta Dueñas; M Fernanda Lara; Xabier Agirre; Felipe Prosper; Ramón García-Escudero; Jesús M Paramio
Journal:  Sci Rep       Date:  2012-11-09       Impact factor: 4.379

Review 10.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.